Intravitreal administration of antisense oligonucleotides: potential of liposomal delivery.
about
Liposomes and nanotechnology in drug development: focus on ocular targetsEnhanced activity of antisense phosphorothioate oligos against leishmania amastigotes: augmented uptake of oligo, ribonuclease H activation, and efficient target intervention under altered growth conditions.Drug delivery from ocular implants.Ocular and systemic bio-distribution of rhodamine-conjugated liposomes loaded with VIP injected into the vitreous of Lewis rats.Novel approaches to retinal drug delivery.Optimizing efficacy of Amphotericin B through nanomodification.Nano-vectors for the Ocular Delivery of Nucleic Acid-based Therapeutics.Nanocarriers of nanotechnology in retinal diseases.Pharmacokinetics of intravitreal antibiotics in endophthalmitis.Enhancing the pharmacokinetic/pharmacodynamic properties of therapeutic nucleotides using lipid nanoparticle systems.Effects of autocrine vascular endothelial growth factor (VEGF) in non-small cell lung cancer cell line A549.Diffusion Regulation in the Vitreous Humor.The application of antisense technology to medicine.Synthesis of taurine-fluorescein conjugate and evaluation of its retina-targeted efficiency in vitro.Synthetic hydrogels as carriers in antisense therapy: preliminary evaluation of an oligodeoxynucleotide covalent conjugate with a copolymer of 1-vinyl-2-pyrrolidinone and 2-hydroxyethyl methacrylate.
P2860
Q27687657-3A03A6AC-4054-4351-A991-6DD2037171C8Q34904790-6D4F9A66-6161-4CC1-A98D-5BB0F7CA43EAQ36409058-DB115604-C3C3-4F0E-A7DE-4C176C6E42D6Q36498879-93AF7DC6-C3D5-4379-BE2F-C34BA83F2A4DQ36903801-4614BBCF-DAA5-44F6-A4E6-6B0B374E9A5CQ37178176-AF6A51A9-B9FA-470E-9AE4-33B5F11BE4AAQ37942156-9289B26F-E1FB-4AAC-986C-3335AD3B48AEQ38282885-414418B0-7CD7-480D-9109-DAC893642637Q38350572-96118D00-141C-4581-8EA9-BE77CAAA6FE8Q38591825-D1DE70DF-DB29-46F9-AC47-1B9012C6C0BBQ39185508-E1D40F4E-1663-40DF-B116-4AA322CF0CB1Q41946889-6F175BDD-5E94-49F9-9391-E1369BFA080AQ42762515-983C46B1-B36E-4565-8EF1-9F056066A4BBQ43193542-84561722-4C2F-42D2-8CF9-4AC26072C59AQ43597101-972E90F5-4321-4285-B55E-125DD919400A
P2860
Intravitreal administration of antisense oligonucleotides: potential of liposomal delivery.
description
2000 nî lūn-bûn
@nan
2000 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մարտին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Intravitreal administration of ...... tential of liposomal delivery.
@ast
Intravitreal administration of ...... tential of liposomal delivery.
@en
type
label
Intravitreal administration of ...... tential of liposomal delivery.
@ast
Intravitreal administration of ...... tential of liposomal delivery.
@en
prefLabel
Intravitreal administration of ...... tential of liposomal delivery.
@ast
Intravitreal administration of ...... tential of liposomal delivery.
@en
P1476
Intravitreal administration of ...... otential of liposomal delivery
@en
P2093
Couvreur P
P304
P356
10.1016/S1350-9462(99)00014-2
P577
2000-03-01T00:00:00Z